Daily news email for July 21, 2010 | Click here for updated news
SourceSolution News
New reporting features added to the Supplier Relationship Management system. Sign up here for our daily webinar to learn more.
Search over 86,000 clinical trials by phase of development and indication at www.sourcesolution.com
PlanIt client portal software lets you exchange and track documents, manage budgets and assign tasks. 3 day implementation!
|
BioSpace
Legal Charge Slashes GlaxoSmithKline Quarterly Profit, Said to Have Paid $1 Billion Over Paxil Suits
New Way to Target Viruses Could Make Antiviral Drugs More Effective, University of Edinburgh Study
HPV Vaccine Gives Prolonged Protection Against Genital Warts and Low-Grade Pre-Cancerous Growths, Study in
Unlocking The Secrets Of Cellular Energy Holds Promise For Obesity, Diabetes And Cancer, University of California, Los Angeles (UCLA) Study
New Genetic Marker of Ovarian Cancer Risk Discovered By Yale University Researchers
|
BioSpace - Breaking News
Ariad Pharmaceuticals, Inc. to Webcast Conference Call on Second Quarter 2010 Financial Results
Gilead Sciences, Inc. Announces Second Quarter 2010 Financial Results
Osiris Therapeutics, Inc. Release: Prochymal New Drug Submission Granted Priority Review by Health Canada
Two Industry Leaders - Proliant Inc. and Lampire Biological Laboratories, Inc. - Form Strategic Partnership to Provide Bovine Serum Albumin
BioMimetic Therapeutics, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option
|
Biotech News - Business Wire
Synovis Life Technologies Celebrates Its 25th Anniversary
Exact Sciences to Host Second-Quarter 2010 Conference Call
BioMimetic Therapeutics Announces Closing of Public Offering and Exercise of Over-Allotment Option
Vascular Solutions to Present at the 30th Annual Canaccord Genuity Growth Conference
Belgian Red Cross-Flanders Selects CaridianBCT's Mirasol® Pathogen Reduction Technology System
|
Biotech News - PR Newswire
Chimerix Appoints Two New Vice Presidents to Clinical Management Team
Keryx Biopharmaceuticals, Inc. Announces Appointment of Joseph Feczko, M.D. to Board of Directors
Keck Graduate Institute Receives $3.6 Million NIH Grant
Precision Antibody Selected to Provide Antibody Characterization for National Cancer Institute's Clinical Proteomics Technologies for Cancer (CPTC) Initiative
United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010
|
Biotechnology - Moreover
A5 Labs Signs Analytical Services Contract With BioActif Inc.
SemBioSys names Pierce U.S., Int'l president
Vietnamese biotech has a healthy future
OXiGENE has the Highest Upside Potential in the Biotechnology Industry (OXGN, RXII, PRAN, PPHM, XOMA)
NAWG Leaders Attend USW Meeting to Talk Trade, Biotech
|
